United States. Department of Health and Human Services. Office of Inspector General. (2010). End stage renal disease drugs: Facility acquisition costs and future Medicare payment concerns. Department of Health and Human Services, Office of Inspector General.
Chicago Style (17th ed.) CitationUnited States. Department of Health and Human Services. Office of Inspector General. End Stage Renal Disease Drugs: Facility Acquisition Costs and Future Medicare Payment Concerns. Washington, D.C.: Department of Health and Human Services, Office of Inspector General, 2010.
MLA (9th ed.) CitationUnited States. Department of Health and Human Services. Office of Inspector General. End Stage Renal Disease Drugs: Facility Acquisition Costs and Future Medicare Payment Concerns. Department of Health and Human Services, Office of Inspector General, 2010.